Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emerald Health Therapeutics Inc
(OP:
EMHTF
)
N/A
UNCHANGED
Last Price
Updated: 3:42 PM EST, Nov 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0405
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
November 10, 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
October 18, 2022
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Performance
More News
Read More
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
September 30, 2022
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
The Canadian Cannabis Report - Monday, Sept. 12
September 12, 2022
Via
Talk Markets
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
August 31, 2022
Via
Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
August 26, 2022
Via
Newsfile
HYTN Awarded Medical Cannabis Sales License By Health Canada
August 23, 2022
Via
Benzinga
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
August 19, 2022
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
July 11, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, July 4
July 04, 2022
Via
Talk Markets
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
July 04, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, June 20
June 20, 2022
Via
Talk Markets
Skye Bioscience Signs Arrangement Agreement With Emerald Health Therapeutics, Here Are The Details
May 12, 2022
Via
Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
May 12, 2022
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
The Canadian Cannabis Report - Monday, March 28
March 28, 2022
Via
Talk Markets
HYTN Innovations To Accept Cannabis Orders Directly From Provinces & Territories
March 17, 2022
Via
Benzinga
The Canadian Cannabis Report - Monday, Mar. 7
March 07, 2022
Via
Talk Markets
HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
February 22, 2022
Via
Benzinga
Emerald Health Therapeutics Sells Patents to FlowerPod
January 11, 2022
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
The Canadian Cannabis Report - Monday, Jan. 3
January 03, 2022
Via
Talk Markets
The Canadian Cannabis Report- Monday, Dec. 27
December 27, 2021
Via
Talk Markets
The Canadian Cannabis Report- Monday, Dec. 20
December 20, 2021
Via
Talk Markets
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
November 29, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
November 29, 2021
Via
Newsfile
Topics
Cannabis
Exposures
COVID-19
Cannabis
The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10%
November 23, 2021
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.